The health system is inadequately prepared for the challenges of addressing the health needs of HIV-positive individuals, according to the report "HIV Screening and Access to Care," published online March 17 by the Institute of Medicine of the National Academies.
TUESDAY, March 29 (HealthDay News) -- The health system is inadequately prepared for the challenges of addressing the health needs of HIV-positive individuals, according to the report "HIV Screening and Access to Care," published online March 17 by the Institute of Medicine of the National Academies.
Paul D. Cleary, Ph.D., from the Yale School of Public Health in New Haven, Conn., and colleagues from the committee on HIV Screening and Access to Care evaluated the current capacity of the health care system to accommodate newly diagnosed HIV-positive individuals into care.
The committee found that increased HIV testing initiatives have led to more HIV-positive diagnoses and more individuals requiring care; as a result, the health care system is increasingly unable to meet these requirements. They also found that ageing and retiring HIV health care providers are not being replaced, with only a small number of new providers specializing in HIV care. Serious inadequacies were also found in HIV-care training, especially practical experience in outpatient settings, where most routine care occurs. The committee suggests that strategies, such as task-shifting, co-management, care coordination, and integrated delivery systems should be implemented to increase the supply of HIV-trained providers.
"Regardless of the approach taken, the committee was impressed by the urgency of addressing these HIV/AIDS care capacity issues. With each additional HIV infection detected, the care system inherits a responsibility to counsel, refer, treat, and monitor an additional patient," the authors write.
Related Content
Is Medicare Dangerous to Your Patient’s Health? If They Have Ovarian Cancer, Yes
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More